Search Tag: PSMA PET/CT

2025 09 Nov

  Prostate-specific membrane antigen PET/CT using fluorine-18 PSMA-1007 is being used to stage prostate cancer before treatment. Beyond image quality, the tracer’s practical features support routine deployment and may help visualise pelvic disease. A systematic review and metaanalysis pooled results from clinical studies that compared imaging directly...Read more

2025 25 Oct

  Prostate-specific membrane antigen (PSMA) PET/CT has transformed prostate cancer assessment and is now embedded in guideline-recommended care. Yet the usefulness of advanced imaging depends on how consistently results are communicated. An analysis of consecutive external PSMA PET/CT reports received at a single tertiary centre highlights substantial...Read more

2018 14 Feb

German researchers have found a new marker for differentiating cancerous tissue from healthy tissue in prostate cancer patients. Based on their study, the maximum standardised uptake value (SUVmax) on Gallium-68 prostate specific membrane antigen (68Ga-PSMA) PET/CT scans correlates with PSMA-expression in primary prostate cancer. With this method,...Read more